Immunization method against Neisseria meningitidis serogroups A and C

Details for Australian Patent Application No. 2004251742 (hide)

Owner Aventis Pasteur, Inc.

Inventors Ryall, Robert P.

Agent Spruson & Ferguson

Pub. Number AU-A-2004251742

PCT Pub. Number WO2005/000345

Priority 60/480,925 23.06.03 US

Filing date 23 June 2004

Wipo publication date 6 January 2005

International Classifications

A61K 39/095 (2006.01) Medicinal preparations containing antigens or antibodies - Neisseria

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/000345 Priority application(s): WO2005/000345

9 February 2006 Change of Name(s) of Applicant(s), Section 104

  Aventis Pasteur, Inc. The name of the applicant has been changed to Sanofi Pasteur, Inc.

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251744-The polymorphic Form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-p ropylphenylthio)propoxy]-2-propylphenoxy]butryric acid

2004251734-Vaccines against group Y neisseria meningitidis and meningococcal combinations thereof